Dennis, Emily L. http://orcid.org/0000-0001-7112-4009
Disner, Seth G.
Fani, Negar http://orcid.org/0000-0002-7720-252X
Salminen, Lauren E.
Logue, Mark
Clarke, Emily K. http://orcid.org/0000-0003-3553-2990
Haswell, Courtney C.
Averill, Christopher L.
Baugh, Lee A.
Bomyea, Jessica
Bruce, Steven E.
Cha, Jiook
Choi, Kyle
Davenport, Nicholas D.
Densmore, Maria
du Plessis, Stefan
Forster, Gina L.
Frijling, Jessie L.
Gonenc, Atilla
Gruber, Staci
Grupe, Daniel W. http://orcid.org/0000-0003-4927-7572
Guenette, Jeffrey P. http://orcid.org/0000-0002-4684-5469
Hayes, Jasmeet
Hofmann, David
Ipser, Jonathan
Jovanovic, Tanja
Kelly, Sinead
Kennis, Mitzy
Kinzel, Philipp
Koch, Saskia B. J. http://orcid.org/0000-0002-3628-6712
Koerte, Inga http://orcid.org/0000-0003-1281-9286
Koopowitz, Sheri
Korgaonkar, Mayuresh
Krystal, John
Lebois, Lauren A. M. http://orcid.org/0000-0001-5816-9181
Li, Gen
Magnotta, Vincent A.
Manthey, Antje
May, Geoff J.
Menefee, Deleene S.
Nawijn, Laura
Nelson, Steven M.
Neufeld, Richard W. J.
Nitschke, Jack B.
O’Doherty, Daniel
Peverill, Matthew http://orcid.org/0000-0002-8257-1004
Ressler, Kerry J.
Roos, Annerine
Sheridan, Margaret A.
Sierk, Anika http://orcid.org/0000-0002-1396-8075
Simmons, Alan
Simons, Raluca M.
Simons, Jeffrey S.
Stevens, Jennifer http://orcid.org/0000-0003-4674-0314
Suarez-Jimenez, Benjamin
Sullivan, Danielle R. http://orcid.org/0000-0002-0141-5887
Théberge, Jean http://orcid.org/0000-0001-7578-4469
Tran, Jana K.
van den Heuvel, Leigh http://orcid.org/0000-0003-3884-4754
van der Werff, Steven J. A.
van Rooij, Sanne J. H. http://orcid.org/0000-0002-0160-7248
van Zuiden, Mirjam
Velez, Carmen
Verfaellie, Mieke
Vermeiren, Robert R. J. M.
Wade, Benjamin S. C.
Wager, Tor http://orcid.org/0000-0002-1936-5574
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Winternitz, Sherry
Wolff, Jonathan
York, Gerald
Zhu, Ye
Zhu, Xi
Abdallah, Chadi G. http://orcid.org/0000-0001-5783-6181
Bryant, Richard http://orcid.org/0000-0002-9607-819X
Daniels, Judith K
Davidson, Richard J
Fercho, Kelene A
Franz, Carol
Geuze, Elbert http://orcid.org/0000-0003-3479-2379
Gordon, Evan M
Kaufman, Milissa L
Kremen, William S.
Lagopoulos, Jim
Lanius, Ruth A
Lyons, Michael J.
McCauley, Stephen R
McGlinchey, Regina
McLaughlin, Katie A.
Milberg, William
Neria, Yuval
Olff, Miranda
Seedat, Soraya http://orcid.org/0000-0002-5118-786X
Shenton, Martha
Sponheim, Scott R. http://orcid.org/0000-0002-2782-0856
Stein, Dan J. http://orcid.org/0000-0001-7218-7810
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Straube, Thomas
Tate, David F. http://orcid.org/0000-0003-0213-1920
van der Wee, Nic J. A.
Veltman, Dick J.
Wang, Li.
Wilde, Elisabeth A.
Thompson, Paul M.
Kochunov, Peter
Jahanshad, Neda
Morey, Rajendra A.
Article History
Received: 20 June 2019
Revised: 20 November 2019
Accepted: 2 December 2019
First Online: 19 December 2019
Compliance with ethical standards
:
: CGA has served as a consultant, speaker and/or on advisory boards for FSV7, Lundbeck, Genentech and Janssen, and editor of Chronic Stress for Sage Publications, Inc.; he has filed a patent for using mTOR inhibitors to augment the effects of antidepressants (filed on August 20, 2018). RJD is the founder and president of, and serves on the board of directors for, the nonprofit organization Healthy Minds Innovations, Inc. JK is a consultant for AbbVie, Inc., Amgen, Astellas Pharma Global Development, Inc., AstraZeneca Pharmaceuticals, Biomedisyn Corporation, Bristol-Myers Squibb, Eli Lilly and Company, Euthymics Bioscience, Inc., Neurovance, Inc., FORUM Pharmaceuticals, Janssen Research & Development, Lundbeck Research USA, Novartis Pharma AG, Otsuka America Pharmaceutical, Inc., Sage Therapeutics, Inc., Sunovion Pharmaceuticals, Inc., and Takeda Industries; is on the Scientific Advisory Board for Lohocla Research Corporation, Mnemosyne Pharmaceuticals, Inc., Naurex, Inc., and Pfizer; is a stockholder in Biohaven Pharmaceuticals; holds stock options in Mnemosyne Pharmaceuticals, Inc.; holds patents for Dopamine and Noradrenergic Reuptake Inhibitors in Treatment of Schizophrenia, US Patent No. 5,447,948 (issued September 5, 1995), and Glutamate Modulating Agents in the Treatment of Mental Disorders, U.S. Patent No. 8,778,979 (issued July 15, 2014); and filed a patent for Intranasal Administration of Ketamine to Treat Depression. U.S. Application No. 14/197,767 (filed on March 5, 2014); US application or Patent Cooperation Treaty international application No. 14/306,382 (filed on June 17, 2014). Filed a patent for using mTOR inhibitors to augment the effects of antidepressants (filed on August 20, 2018). NJ received partial research support from Biogen, Inc. (Boston, USA) for research unrelated to the content of this paper. PMT received partial research support from Biogen, Inc. (Boston, USA) for research unrelated to the topic of this paper.